SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs demonstration of an end-to-end real-time quantum error-correction decoder running on a standard CPU is the main catalyst, with traders viewing it as progress toward fault-tolerant quantum computing and a potential industry-wide boost. The announcement drew bullish momentum and short-squeeze speculation, alongside skepticism about whether the technical milestone justifies the stocks valuation or can sustain gains.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtions integration of its quantum error-correction software with NVIDIA CUDA-Q Logical is the main catalyst, with the company reporting a code that could use fewer physical qubits per logical qubit. Traders are upbeat about the technical progress and NVIDIA association, but many are frustrated that the stocks reaction has been muted amid broader market pressure and volatility in quantum shares.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is drawing attention after VK2735 study data showed patients maintained most of their weight loss on less-frequent injections, bolstering optimism about the obesity drugs potential. Traders are celebrating the results and analyst support, while debating the stocks follow-through, possible dilution, and speculative partnership or buyout prospects.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense and Space Technologies, and Starlab Space Stations. The Defense and Space Technologies segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyagers proposed $350 million convertible senior notes offering is driving attention, with traders concerned about potential dilution and frustrated by what they see as repeated fundraising. Some view the selloff as a buying opportunity, but the dominant reaction is negative.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

HBARs sharp move higher toward the $0.10 level has traders discussing a possible technical breakout, while some speculate that expectations around the CLARITY Act are helping sentiment. The reaction is mixed: bulls see renewed momentum, while skeptics question whether the move can hold and point to resistance and previous failed rallies.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The S&P 500 removal and related index rebalancing dominate discussion, with traders attributing unusually heavy volume and selling pressure to funds adjusting their holdings as TTD moved to the S&P SmallCap 600. Traders debate how much of the decline is technical versus driven by concerns about slowing growth, competition, and management; bearish frustration is met by some oversold-bounce buying.

Royal Caribbean Group is a cruise company, which engages in the ownership and operation of the following global cruise brands: Royal Caribbean International, Celebrity Cruises, and Silversea Cruises. The firm also holds interest in TUI Cruises GmbH, which operates the German brands TUI Cruises and Hapag-Lloyd Cruises. The company was founded by Arne Wilhelmsen in 1968 and is headquartered in Miami, FL.

Royal Caribbean Group

Reports that Royal Caribbean is nearing a deal to take control of Sandals Resorts have fueled the selloff, with traders debating the cost and potential debt or share dilution. Some see the acquisition as a costly distraction, while others view Sandals resort business as a profitable strategic fit with cross-selling potential.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

INODs sharp rally is being attributed mainly to a breakout above a key resistance level and possible short covering, while some traders speculate it is tied to reports linking Innodatas AI work to Metas Muse; that connection remains unconfirmed. The discussion is divided between bullish momentum and caution that no company-confirmed catalyst has been announced.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Uncertainty over the TensorWave leases financial backstop and the extension of its closing deadline are driving concern about whether Fermi can finance and execute its AI data-center project. Traders also debate whether former CEO Toby Neugebauers legal fight with the board is adding to the delay, while some remain bullish on the projects potential tenant demand.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

PENGUs sharp move higher has traders focused on renewed momentum and a possible breakout, with some linking the enthusiasm to a broader crypto-market rally and Bitcoin strength. Bulls are cheering the move and accumulating, while skeptics warn that gains may fade amid profit-taking and meme-coin volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BBOT Appears to have gone completely under the radar. They are attended 3 separate events within a week, the first of which is tomorrow. readouts from all 3 assets imminent.

StockTwits Web

BridgeBio Oncology Therapeutics Inc.

 Appears to have gone completely under the radar. They are attended 3 separate events within a week, the first of which is tomorrow. readouts from all 3 assets imminent.

Bag Holder

@ihatemyjob77 8520 plus pembrolizumab demonstrated a 75% ORR at 500 mg QD and 53% ORR across dose levels in 2L+ KRASG12C inhibitor-experienced NSCLC patients
BBO-8520 monotherapy continues to show highly competitive ORR in the 2L+ KRASG12C inhibitor-naïve NSCLC with ORR of 63% (26/41), disease control rate (DCR) of 100% (41/41) and no grade 3 liver enzyme elevations
BBO-11818 and BBO-10203 combination cohorts enrolling in KRAS-mutant CRC and PDAC

StockTwits for iOS

 8520 plus pembrolizumab demonstrated a 75% ORR at 500 mg QD and 53% ORR across dose levels in 2L+ KRASG12C inhibitor-experienced NSCLC patients
BBO-8520 monotherapy continues to show highly competitive ORR in the 2L+ KRASG12C inhibitor-naïve NSCLC with ORR of 63% (26/41), disease control rate (DCR) of 100% (41/41) and no grade 3 liver enzyme elevations
BBO-11818 and BBO-10203 combination cohorts enrolling in KRAS-mutant CRC and PDAC